HIGHFDA DRUG

Novo Nordisk Recalls Wegovy Injection Due to Contamination Risk

Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
December 19, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 19, 2025
Hazard Level
HIGH
Brands
Wegovy, Novo Nordisk
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Wegovy, Novo Nordisk
Product type
Injection
Model numbers
Lot #: RZFYK06, RZFYA53
UPC codes
0169-4404, 0169-4525, 0169-4505, 0169-4501, 0169-4517, 0169-4524, 0169-4415, 0169-4409 +11 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 19, 2025

  2. Reported by FDA DRUG

    January 7, 2026

  3. RecallRadar source check

    January 14, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Particulate Matter: Hair was found in a prefilled syringe

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Novo Nordisk Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

Wegovy is an injectable medication utilized for weight management in adults with obesity or overweight conditions. Consumers typically purchase it as part of a comprehensive weight loss program under medical supervision.

Why This Is Dangerous

The presence of hair in the prefilled syringe raises contamination concerns, which can lead to serious health risks if injected. Contamination can introduce pathogens or foreign materials into the body.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers should stop using Wegovy and seek alternatives for their weight management needs. The recall may cause inconvenience and requires immediate action to ensure safety.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your Wegovy injection pens.
  2. Verify if your pens are Lot #: RZFYK06 or RZFYA53.
  3. Review the expiration date to confirm validity.

Where to find product info

The lot number and expiration date can be found on the packaging of the product and on the prefilled pens themselves.

What timeline to expect

Expect a refund or further instructions within 4-6 weeks after contacting Novo Nordisk.

If the manufacturer is unresponsive

  • Document all communication attempts with Novo Nordisk.
  • Follow up with your healthcare provider for further assistance.
  • Consider filing a complaint with the FDA if necessary.

How to prevent similar issues

  • Always check for recalls on medications before use.
  • Consult your healthcare provider if you notice any unusual materials in injectable products.
  • Ensure you buy medications from reputable sources.

Documentation advice

Keep a record of your purchase, including receipts and any correspondence with Novo Nordisk regarding the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, includes four single-dose prefilled pens. The affected lots are Lot #: RZFYK06 and RZFYA53, with an expiration date of March 31, 2027. The product is manufactured by Novo Nordisk A/S, Bagsvaerd, Denmark, and distributed in the U.S.

Key Facts

  • Recall date: December 19, 2025
  • High hazard level
  • Class II recall
  • No injuries reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: RZFYK06
RZFYA53
UPC Codes
0169-4404
0169-4525
0169-4505
+16 more
Affected States
ALL
Report Date
January 7, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more